首页/数据集/Adverse events reported in ≥4% of participants (total).

Adverse events reported in ≥4% of participants (total).

Figshare2018-06-07 更新2026-04-29 收录

药物安全性评估

临床试验不良事件

数据链接：

https://figshare.com/articles/dataset/Adverse_events_reported_in_4_of_participants_total_/6457658 数据链接链接失效反馈

官方服务：

资源简介：

Adverse events reported in ≥4% of participants (total).

应用场景：

创建时间：

2018-06-07

药物安全性评估

癌症治疗不良反应

Nr: Not reported. *Data from CATT appendix: they refer to duodenal ulcer haemorrhage, gastric ulcer haemorrhage, (lower) gastrointestinal haemorrhage, rectal haemorrhage. #Rates refer mainly to pneumo

NIAID Data Ecosystem110

Post-treatment adverse events (AEs) by category and treatment group that were recorded within 7 days of treatment.

药物安全性评估

临床试验不良事件

Post-treatment adverse events (AEs) by category and treatment group that were recorded within 7 days of treatment.

Figshare2023-05-19 更新30

5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis

药物安全性评估

男性乳腺癌风险

Abstract Objective: To assess the relationship between 5α-reductase inhibitors (5ARIs) and the risk of male breast cancer (MBC). Material and Methods: We systematically searched Medline via PubMed,

NIAID Data Ecosystem20

Treatment-emergent adverse events during the treatment period (SAS).

HIV药物安全性监测

临床试验不良事件

Treatment-emergent adverse events during the treatment period (SAS).

NIAID Data Ecosystem70

DataSheet1_Serious Adverse Events Reporting in Phase III Randomized Clinical Trials of Colorectal Cancer Treatments: A Systematic Analysis.docx

结直肠癌临床研究

药物安全性评估

Objective: The occurrence, development, and prognosis of serious adverse events (SAEs) associated with anticancer drugs in clinical trials have important guiding significance for real-world clinical a

NIAID Data Ecosystem30

Adverse events reported in ≥4% of participants (total).

资源简介：

相关数据集